Senior Faculty Scholars

Marina Chiara Garassino, MD, is an internationally recognized expert in the treatment of thoracic malignancies.

Dr. Garassino graduated from the Medical School of Università degli Studi of Milan, Italy, where she also completed her training in Medical Oncology. After a fellowship at the Christie’s Hospital in Manchester (UK), she served as a physician oncologist in prestigious Italian cancer centers. She has risen to lead the Thoracic Medical Oncology Unit at one the most renowned comprehensive cancer center in Italy, the Istituto Nazionale dei Tumori of Milan.

She leads the strategy for clinical and translational research in advanced and locally advanced NSCLC, mesothelioma, thymoma and thymic carcinoma due to her effort in the research of drugs development, precision medicine and in immuno-oncology. She gave her contribute as author or coauthor to over 200 peer-reviewed publications, including many publications as first or last author in the Lancet Oncology, Journal of Clinical Oncology, Annals of Oncology, and the New England Journal of Medicine. Some of her publications radically changed the treatment paradigm of and treatment guidelines for lung cancer around the world.

In response the COVID-19 emergency, Dr. Garassino established and brought together an international group of physicians and investigators to study the impact of COVID-19 on patients with lung cancer. This led to the initiation of the Thoracic Cancers International COVID‐19 Collaboration, or TERAVOLT, a global registry for patients with thoracic cancers and COVID‐ 19. Currently, 180 centers from 25 countries have joined the consortium. Data from this consortium have already been ascertained and published in Lancet Oncology and Cancer Cell.

Dr. Garassino has been the recipient of many international awards from prestigious organizations like the American Society of Clinical Oncology, and she is the founder and president of Women for Oncology Italy. She provides strong support in gender equalities believing in the importance and value of creating an environment with diversity.

Dr. Edward Garrity is a Pulmonary and Critical Care Specialist focused on lung transplantation and the management of advanced lung diseases. Dr. Garrity is considered to be among the early adopters of lung transplantation as therapy for chronic lung diseases.

Dr. Garrity was deeply involved in the development of the current system for allocation of donor lungs for transplantation, and helped to reduce mortality of those awaiting the life-giving organs. Ed joined the faculty at The University of Chicago as a Professor of Medicine in 2005.

Dr. Garrity pursued a long-standing interest in Ethics via The MacLean Center for Clinical Medical Ethics fellowship in 2017. He continues to devote energy to the Pritzker School of Medicine Admissions Committee and his own abiding interest in the compassionate care of his patients, including those served through the Bridgeport Free Clinic. Dr. Garrity is recognized as a wonderful doctor, who always does his best for his patients and who works to instill that same desire in his students and trainees.

Dr. Melissa Gilliam is Professor of Obstetrics & Gynecology and Pediatrics, Chief of the Section of Family Planning & Contraceptive Research, and Associate Dean for Diversity and Inclusion in the Biological Sciences Division, as well as Director of Ci3 at the University of Chicago.

An expert in pediatric and adolescent gynecology, Dr. Melissa Gilliam helps children, teens and women age 25 and younger who have complex gynecologic problems or need routine care. Dr. Gilliam specializes in managing common problems such as bleeding, painful periods, breasts cysts and abnormal pap smears and complex problems requiring pelvic surgery. She has expertise in providing preventive care and providing contraception to adolescents with other medical problems. Dr. Gilliam focuses on providing a youth-friendly atmosphere for girls and young women. She works closely with other specialists across the University.

An active researcher, Dr. Gilliam’s research focuses on contraception, family planning, youth development, and sexually transmitted infections. Specifically, she focuses on contraceptive use among teens and women who are at risk for unintended pregnancy.

In 2021, Dr. Gilliam was named Provost of Ohio State University.

Dr. David Glick is a Professor in the Department of Anesthesia & Critical Care. His clinical interests include the anesthetic management of vascular, thoracic and head and neck cancer patients as well as the care of patients in the Post-Anesthesia Care Unit (for which he has been the medical director since 2002). His research interests cover a wide range of clinical questions including the feasibility of processed EEG monitoring to decrease the risk of intra-operative awareness, the incidence of and risk factors for the development of deep venous clots around the time of surgery, ways to facilitate emergence from general anesthetics in children and patients for whom English is not the first language, the value and impact of surgical quality metrics, and the optimization of awake intubation techniques. He has published widely in these areas and students and residents in his lab have presented well over 100 abstracts at national and international meetings. He has received multiple awards for teaching and research mentorship and has been a track leader/cluster group leader for the clinical research tracks of the Pritzker Summer Research Program and the Scholarship & Discovery track for many years. Dr. Glick is currently Head of the Anesthesiology Department at the University of Illinois at Chicago.

Dr. Golden is Associate Professor, Medical Student Clerkship Director, and Associate Residency Program Director in the Department of Radiation and Cellular Oncology. He completed residency at the University of Chicago. He is a graduate of the Pritzker School of Medicine Medical Education Research Innovation Teaching and Scholarship (MERITS) fellowship and completed a Masters of Health Professions Education (MHPE) at the University of Illinois at Chicago.

Dr. Golden’s clinical practice is at the University of Chicago Medicine Comprehensive Cancer Center at Silver Cross where he treats a broad array of cancers with external beam radiation. Dr. Golden focuses on educating his patients about their disease and treatment process with the goal of reducing anxiety and improving treatment compliance and outcomes.

His academic interests focus on patient and trainee education. In 2017 Dr. Golden received a pilot grant from the Bucksbaum Institute to develop a graphic narrative discussion guide to help providers communicate to patients what to expect during the radiotherapy treatment process.  Along with additional extramural funding from the Radiation Oncology Institute and collaborators at The University of Chicago, IIT Institute of Design, UIC, and Harvard, he has since developed a series of seven Communicating the External Beam Radiotherapy Experience (CEBRE) guides and three Communicating the Gynecologic Brachytherapy Experience (CoGBE) guides. In addition, the CEBRE en Español guides are culturally appropriate translations of the original CEBRE guides in Spanish.  The discussion guides have been downloaded for use internationally.  Dr. Golden also founded the Radiation Oncology Education Collaborative Study Group (ROECSG), which develops, implements, and evaluates radiation oncology curricular innovations using a collaborative group study model. As of 2022 ROECSG has over 600 members representing more than 200 member institutions around the globe.  Dr. Golden enjoys spending time teaching and mentoring medical students and residents and he received the Radiation and Cellular Oncology Resident Physician teaching award in 2015. As of 2023, Dr. Golden has joined the Radiation Oncology staff at Rush University in Chicago, IL.

Dr. Fernando D. Goldenberg is an Associate Professor in the Departments of Neurology and Surgery (Neurosurgery) at the University of Chicago. He holds the positions of Director of Neuroscience Critical Care Medicine and Co-Director of the Comprehensive Stroke Center.

Dr. Goldenberg earned his medical degree from the University of Buenos Aires School of Medicine in Argentina. He then completed his Internal Medicine residency training in Argentina followed by training in Critical Care Medicine and a fellowship in Neurocritical Care at the Cleveland Clinic. He later joined the University of Chicago in 2002.

Dr. Goldenberg is a contributor to a wide range of research related to the care of critically ill neurological and neurosurgical patients. His current investigations focus on traumatic brain injury, brain death, prognostication after anoxic brain injury and the neurological complications of patients with implanted left ventricular assist devices.

His passion for teaching led him to develop a very successful online educational tool for physicians on Neurocritical Care and Stroke and is currently developing a similar one focused on nursing care.

An active speaker, Dr. Goldenberg has lectured on stroke and brain injury at medical meetings in the United States, Europe, and South America.

Dr. Perpetua Goodall is an Associate Professor of Obstetrics and Gynecology. She completed her undergraduate degree in Chemistry at Northwestern University. She graduated from Meharry Medical College and completed her residency in General Obstetrics and Gynecology at the University of Chicago. Immediately following residency, she joined the faculty in the OB/GYN department at the University of Chicago and has developed one of the largest clinical practices within the department. She is committed to providing comprehensive quality care for women throughout their reproductive lifespan from adolescence to menopause. She is particularly skilled in minimally invasive surgical techniques, including robotic and laparoscopic hysterectomies. She has been involved in clinical trials focusing on alternative treatment options for fibroids. As a respected clinical educator, Dr. Goodall is actively involved in both resident and medical student training and has received several teaching awards. She has held important leadership positions including Assistant Residency Program Director and Division Chief of General Obstetrics and Gynecology.

Dr. Goodall is now a Bucksbaum Senior Faculty Scholar.

Dr. Lawrence Gottlieb is an internationally known reconstructive plastic surgeon. Dr. Gottlieb’s clinical and research interests include: reconstructive microsurgery, the care of patients with burn injuries, difficult wounds, complex reconstructive needs, as well as challenging clinical medical and surgical ethical problems.

Dr. Gottlieb joined the faculty at the University of Chicago in 1984 and is currently Professor of Surgery, Director of the Burn and Complex Wound Center, and a faculty member of the MacLean Center for Clinical Medical Ethics. He works with many different multidisciplinary teams to provide comprehensive state-of-art treatment to a wide variety of patients.

Dr. Gottlieb is an ardent supporter of resident education and academic achievement. He is currently Vice President of The American Society for Reconstructive Microsurgery and has received many honors and awards including: the Department of Surgery ‘Excellence in Teaching Award’, The Section of Plastic Surgery ‘Robert Parsons Golden Apple Teaching Award’, The Illinois Society of Plastic Surgeons ‘Physician Recognition Award’ and ‘Distinguished Physician Award’ as well as the University of Chicago Biological Sciences Division ‘Distinguished Clinician Award’.

Jon E. Grant, MD, JD, MPH is a Professor of Psychiatry & Behavioral Neuroscience at the University of Chicago where he directs a clinic and research lab on addictive, compulsive and impulsive disorders. Dr. Grant’s research has been funded by the NIMH, NIDA, and private foundations. Dr. Grant received his BSA from the University of Michigan, an MA from the University of Chicago, his JD from Cornell University, an MD from Brown University, and his MPH from Harvard University. Dr. Grant is the author of over 400 peer-reviewed scientific articles, 15 books, is on the editorial board of 8 journals, and is the editor in chief of the Journal of Gambling Studies.

Olwen Hahn, MD, specializes in the diagnosis and treatment of breast cancer and genitourinary malignancies, including bladder, kidney, prostate and testicular cancers.

In addition to her clinical roles, Dr. Hahn serves as the primary investigator on multiple studies that examine the effectiveness of new drugs in breast cancer and renal cancer. She also is a dedicated educator, teaching medical students and post-graduate trainees on a variety of topics, including how to take a medical history and the importance of effective communication between doctors and patients.

Dr. Hahn has authored numerous articles in scientific journals, and has contributed to a leading textbook on molecular targeting in oncology. In 2011, Dr. Hahn was the recipient of the University of Chicago’s Distinguished Clinician Award.

Dr. Hahn is now a Bucksbaum Senior Faculty Scholar.

2012 Pilot Grant Project: Communication Skills Training Program for Oncology Trainees